Status:
COMPLETED
Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
SARS-CoV 2
Respiratory Distress Syndrome, Adult
Eligibility:
All Genders
14-100 years
Brief Summary
This is a case series of patients with COVID-19 admitted to the largest university hospital in Sao Paulo, Brazil, during the 2020 COVID-19 pandemic. Data will be collected prospectively and retrospect...
Detailed Description
In December 2019, an outbreak of Severe Acute Respiratory Syndrome (SARS) attributed to a new coronavirus, called SARS-CoV-2, was described in the Wuhan region of China. This SARS, caused by SARS-CoV-...
Eligibility Criteria
Inclusion
- Being admitted to one of the COVID-19 ICUs during the study period
- Suspected or confirmed COVID-19
- Expected ICU stay greater than 24 hours
Exclusion
- ICU Readmission during the same hospital stay (patients will be evaluated only during their first ICU stay)
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 5 2020
Estimated Enrollment :
1589 Patients enrolled
Trial Details
Trial ID
NCT04378582
Start Date
May 7 2020
End Date
August 5 2020
Last Update
August 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas -HCFMUSP
São Paulo, São Paulo, Brazil, 05403010